U.S. markets open in 6 hours 10 minutes

Citius Pharmaceuticals, Inc. (CTXR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.7300+0.0200 (+1.17%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 4/19/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 7

Trading Information

Stock Price History

Beta (5Y Monthly) 1.54
52-Week Change 3158.59%
S&P500 52-Week Change 348.25%
52 Week High 32.9000
52 Week Low 30.6400
50-Day Moving Average 31.8744
200-Day Moving Average 31.3502

Share Statistics

Avg Vol (3 month) 314.68M
Avg Vol (10 day) 34.82M
Shares Outstanding 5134.7M
Implied Shares Outstanding 6N/A
Float 68.11M
% Held by Insiders 19.14%
% Held by Institutions 16.56%
Shares Short (Mar 30, 2021) 411.03M
Short Ratio (Mar 30, 2021) 41.09
Short % of Float (Mar 30, 2021) 49.02%
Short % of Shares Outstanding (Mar 30, 2021) 48.19%
Shares Short (prior month Feb 25, 2021) 410.11M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jun 08, 2017
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3Jun 08, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Sep 29, 2020
Most Recent Quarter (mrq)Dec 30, 2020


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-44.40%
Return on Equity (ttm)-92.57%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -21.42M
Net Income Avi to Common (ttm)-21.37M
Diluted EPS (ttm)-0.4670
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)4.3M
Total Cash Per Share (mrq)0.06
Total Debt (mrq)1.31M
Total Debt/Equity (mrq)5.09
Current Ratio (mrq)1.57
Book Value Per Share (mrq)0.45

Cash Flow Statement

Operating Cash Flow (ttm)-21.38M
Levered Free Cash Flow (ttm)-13.28M